Skip to main content

Table 2 Univariate analysis with respect to 5-year survival of the patients with non-small cell lung cancer

From: Kinesin superfamily protein 21B acts as an oncogene in non-small cell lung cancer

Clinical featuresPatients5-year survival (%)P Valueb
PatientsRate (%)
 Gender   0.352
 Age, year   0.624
  < 60311238.7 
  ≥ 60411741.5 
 Smoking   0.182
 Histological type   0.115
 Differentiation   0.035
 pT   0.069
 pN   0.001
 pTNM   0.001
 Chemotherapy   0.893
 Radiotherapy   0.801
 EGFR-TKI therapy   0.788
 KIF21B   0.001
  1. SCC squamous cell carcinoma, ADC adenocarcinoma, pT tumor size, pN lymph node metastasis, pTNM tumor stage, EGFR-TKI growth factor receptor-tyrosine kinase inhibitor
  2. P Valueb: Log-rank test